Overview

A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)

Status:
Completed
Trial end date:
2009-01-19
Target enrollment:
Participant gender:
Summary
This study will design an alternative urodynamic platform to better evaluate treatment effects of medications for overactive bladder. Part II is dependent on results of Part I and may not be conducted.
Phase:
Phase 1
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Tolterodine Tartrate